Additionally, variations in tumor‐suppressor genes (like TP53) and oncogenes (like EGFR) may either increase susceptibility or provide protective effects against CNS tumors, contributing to incidence differences among racial and ethnic groups.20, 21. This evidence concerns the gene TP53 and neoplasm.